Clinical Trials Directory

Trials / Completed

CompletedNCT00516776

The Innate Immune System and Inflammatory Bowel Disease

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study includes individuals with ulcerative colitis, Crohn's disease and healthy controls. The purpose of this study is to examine the innate immune system (IIS) by exposing peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study the immune response. Colonic mucosal samples are examined to find gene expression patterns which may distinguish the two forms of disease from each other and from healthy controls. The hypothesis is that the innate immune system has responses unique for the disease states, and that the diseases may be differentiated by examination of gene expression patterns in mucosal biopsies.

Conditions

Timeline

Start date
2007-06-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2007-08-15
Last updated
2018-02-14

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00516776. Inclusion in this directory is not an endorsement.

The Innate Immune System and Inflammatory Bowel Disease (NCT00516776) · Clinical Trials Directory